Related Experiment Video
Updated: Jun 21, 2025
07:46
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
4.7K
Towards targeting the breast cancer immune microenvironment
Michael A Harris1,2, Peter Savas1,2, Balaji Virassamy1,2
1The Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne, Victoria, Australia.
Nature Reviews. Cancer
|July 5, 2024
Summary
The tumor immune microenvironment (TME) involves complex cell interactions influencing cancer therapies. Understanding the TME is crucial for developing effective treatments, especially for breast cancer.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- The tumor immune microenvironment (TME) comprises cancer cells, immune cells, fibroblasts, and endothelial cells, influencing therapeutic outcomes.
- The TME's role is complex, acting as both a target and a modulator for cancer therapies.
- Immune cells, particularly T cells, are critical in triple-negative breast cancer (TNBC) and hormone receptor-positive disease.
Purpose of the Study:
- To review the components of the immune TME in breast cancer.
- To discuss therapies targeting or impacting the immune TME.
- To explore the complexity of host physiology in relation to breast cancer immunity.
Main Methods:
- Literature review of studies on breast cancer immunology and therapeutics.
- Analysis of the role of various cellular components within the TME.
- Examination of current and emerging immunotherapies for breast cancer.
Main Results:
- The immune TME significantly impacts the efficacy of cancer treatments.
- Immune checkpoint inhibitors combined with chemotherapy are standard for TNBC.
- Emerging evidence shows promise for immunotherapies in hormone receptor-positive breast cancer.
Conclusions:
- Targeting the immune TME offers a promising therapeutic strategy for breast cancer.
- A comprehensive understanding of TME components and host interactions is essential for treatment optimization.
- Further research into TME modulation can lead to improved breast cancer patient outcomes.
Related Concept Videos
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:30Cancer Vaccines
350
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
350